Replay
San Diego
About Replay
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $55.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2022)
- Website: replay.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/replay-17263 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.